IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis

BACKGROUND: Methotrexate (MTX) is the standard first-line therapy in rheumatoid arthritis (RA) with variable clinical efficacy that is difficult to predict. The glycosylation status of immunoglobulin G (IgG) is altered in RA and influenced by MTX treatment. We aimed to further investigate if IgG gly...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundström, Susanna L., Hensvold, Aase H., Rutishauser, Dorothea, Klareskog, Lars, Ytterberg, A. Jimmy, Zubarev, Roman A., Catrina, Anca I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549282/
https://www.ncbi.nlm.nih.gov/pubmed/28793911
http://dx.doi.org/10.1186/s13075-017-1389-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549282/
https://www.ncbi.nlm.nih.gov/pubmed/28793911
http://dx.doi.org/10.1186/s13075-017-1389-7

Ejemplares similares